Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.
about
Pharmacokinetics of modified slow-release oral testosterone over 9 days in normal men with experimental hypogonadismDietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal menCardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.Importance of measuring testosterone in enzyme-inhibited plasma for oral testosterone undecanoate androgen replacement therapy clinical trials.
P2860
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@ast
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@en
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@nl
type
label
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@ast
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@en
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@nl
prefLabel
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@ast
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@en
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@nl
P2093
P2860
P1476
Steady-state pharmacokinetics ...... f 5α-reductase by finasteride.
@en
P2093
P Christenson
R E Dudley
R Swerdloff
P2860
P304
P356
10.1111/J.1365-2605.2010.01120.X
P433
P577
2010-10-24T00:00:00Z